The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study*Yan Zhao, J Zhang, Liming Wu et al.|British Journal of Dermatology|2021Cited by 73
[Plural infection by Salmonella O7 group that hospital infection was doubted].Yoko Kaneko, Kazuo Kobayashi, Yumiko Katagiri et al.|PubMed|2006Cited by 1